Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults
Clinical trial NCT03437304 · COMPLETED
Trial details
- NCT number
- NCT03437304
- Sponsor
- Eurocine Vaccines AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-09
- Primary completion
- 2018-06-30
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.